Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-PRC-12002903Phase 4Completed
Phase 4, randomised trial of dexmedetomidine (2 arms), sponsored by Capital Medical University. Primary endpoint: Mean percentage of time in optimal sedation. Started Jul 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-PRC-12002903.